InsiderClusters
Get started

PRLD insider buying

2 cluster buys

Prelude Therapeutics Inc · Healthcare

When two or more insiders at Prelude Therapeutics Inc buy PRLD on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in PRLD plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
2
Distinct insiders
6
Total bought
$25.9M
Market cap
$502.8M

Detected clusters

  • Apr 21 – Apr 21, 2026
    Detected Apr 21, 2026
    2 insiders
    Total bought
    $25.0M
    Market cap
    $502.8M
  • Dec 18, 2024 – Mar 25, 2025
    Detected Mar 25, 2025
    High conviction4 insiders
    Total bought
    $874.4K
    Market cap
    $494.9M

All notable open-market buys in PRLD

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Apr 21, 2026
Bonita David Pcluster
Director, 10% Owner
1,689,189$4.44$7.5MSEC ↗
Apr 21, 2026
ORBIMED ADVISORS LLCcluster
Director, 10% Owner
1,689,189$4.44$7.5MSEC ↗
Apr 21, 2026
Bonita David Pcluster
Director, 10% Owner
1,126,126$4.44$5.0MSEC ↗
Apr 21, 2026
ORBIMED ADVISORS LLCcluster
Director, 10% Owner
1,126,126$4.44$5.0MSEC ↗
Mar 25, 2025
Vaddi Krishnacluster
Director, CEO
675,000$0.69$465.7KSEC ↗
Mar 25, 2025
Combs Andrewcluster
Chief Chemistry Officer
100,000$0.69$69.0KSEC ↗
Mar 21, 2025
Vaddi Krishnacluster
Director, CEO
15,000$0.73$11.0KSEC ↗
Mar 20, 2025
Vaddi Krishnacluster
Director, CEO
5,416$0.73$4.0KSEC ↗
Mar 17, 2025
Vaddi Krishnacluster
Director, CEO
9,106$0.75$6.8KSEC ↗
Mar 14, 2025
Vaddi Krishnacluster
Director, CEO
29,999$0.75$22.5KSEC ↗
Mar 13, 2025
Vaddi Krishnacluster
Director, CEO
50,000$0.72$36.0KSEC ↗
Mar 12, 2025
Vaddi Krishnacluster
Director, CEO
47,500$0.71$33.7KSEC ↗
Dec 31, 2024
Vaddi Krishnacluster
Director, CEO
5,000$1.21$6.1KSEC ↗
Dec 30, 2024
Vaddi Krishnacluster
Director, CEO
10,000$1.20$12.0KSEC ↗
Dec 23, 2024
Combs Andrewcluster
Chief Chemistry Officer
60,000$1.37$82.2KSEC ↗
Dec 20, 2024
Combs Andrewcluster
Chief Chemistry Officer
3,075$1.15$3.5KSEC ↗
Dec 19, 2024
Lim Bryant Davidcluster
CLO, Interim CFO, Corp Sec.
25,000$0.91$22.8KSEC ↗
Dec 19, 2024
Vaddi Krishnacluster
Director, CEO
6,888$0.89$6.1KSEC ↗
Dec 18, 2024
Vaddi Krishnacluster
Director, CEO
100,000$0.93$93.0KSEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

PRLD insider buying — FAQ

Are insiders buying PRLD stock?
Yes — 6 distinct insiders have bought PRLD (Prelude Therapeutics Inc) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Apr 23, 2026.
How much PRLD stock have insiders bought?
Insiders have bought a combined $25.9M of PRLD across 19 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in PRLD?
A cluster buy is two or more distinct Prelude Therapeutics Inc insiders — officers, directors, or 10% owners — each buying PRLD on the open market within a rolling window. PRLD has 2 detected cluster buys to date.
Where does this PRLD insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in PRLD

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy PRLD within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding PRLD.